LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Lantern Pharma Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERLTRN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / LTRN COVERAGE

What’s moving Lantern Pharma Inc. now

Current reporting with the operating signal separated from the noise.

01
TradingView

Price to book forward of Lantern Pharma Inc. – NASDAQ:LTRN

The story matters when it changes Lantern Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
TradingKey

Lantern Pharma Inc (LTRN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

The story matters when it changes Lantern Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor

Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor

The story matters when it changes Lantern Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai AI Platform for Rare Cancer Drug Discovery Transcript

Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai AI Platform for Rare Cancer Drug Discovery Transcript

The development tests whether Lantern Pharma Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
05
Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery Transcript

Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery Transcript

The development tests whether Lantern Pharma Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest LTRN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-03 · Period 2026-08-03SEC ↗8-KMaterial company eventFiled 2026-06-02 · Period 2026-06-01SEC ↗8-KMaterial company eventFiled 2026-05-15 · Period 2026-05-15SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-08-08 · Period 2025-08-08SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-23SEC ↗
EARNINGS / QUARTERLY TRACKER

Lantern Pharma Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.